L. Bergougnan

Differential Effects of Omeprazole and Pantoprazole on the Pharmacodynamics and Pharmacokinetics of Clopidogrel in Healthy Subjects: Randomized, Placebo-Controlled, Crossover Comparison Studies

Dominick J. Angiolillo, C. Michael Gibson, Shuk Han Cheng et al. · Clinical Pharmacology & Therapeutics · 2010 · 277 citations

Genetic Polymorphisms and the Impact of a Higher Clopidogrel Dose Regimen on Active Metabolite Exposure and Antiplatelet Response in Healthy Subjects

Tabassome Simon, Deepak L. Bhatt, L. Bergougnan et al. · Clinical Pharmacology & Therapeutics · 2011 · 89 citations

Troleandomycin-triazolam interaction in healthy volunteers: Pharmacokinetic and psychometric evaluation

D. Warot, L. Bergougnan, Denis Lamiable et al. · European Journal of Clinical Pharmacology · 1987 · 47 citations

Medicine, Troleandomycin-triazolam Interaction, Patient Safety +3

The acute effects of amisulpride (50 mg and 200 mg) and haloperidol (2 mg) on cognitive function in healthy elderly volunteers

Eric Legangneux, John McEwen, Keith Wesnes et al. · Journal of Psychopharmacology · 2000 · 42 citations

Assessment System, Neuropsychology, Aging +22

Modulation of Vasoactivity and Platelet Aggregation by Selective 5-HT Receptor Antagonism in Humans

Matthijs Moerland, Michiel J. B. Kemme, Anneke C. Dijkmans et al. · Journal of Cardiovascular Pharmacology · 2011 · 20 citations